相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Letizia Porcelli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations
T. Kinno et al.
ANNALS OF ONCOLOGY (2014)
TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Sandeep Rajput et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity
Letizia Porcelli et al.
MOLECULAR ONCOLOGY (2013)
Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines
Carolina Hertzman Johansson et al.
MELANOMA RESEARCH (2013)
Challenging resistance mechanisms to therapies for metastatic melanoma
Lucio Tentori et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Mitochondrial Localization and Regulation of BRAF(V600E) in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAF(V600E)
Min Hee Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
Paul K. Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Ras Isoprenylation and pAkt Inhibition by Zoledronic Acid and Fluvastatin Enhances Paclitaxel Activity in T24 Bladder Cancer Cells
Shaojuan Li et al.
Cancers (2011)
BRAF, a Target in Melanoma Implications for Solid Tumor Drug Development
Keith T. Flaherty et al.
CANCER (2010)
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer
Amalia Azzariti et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
MLANA/MART1 and SlLV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma
JY Du et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)